Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Driving in Alzheimer's disease and mild cognitive impairment: An immersive fMRI study
EF 2013-14
Résumé
Driving is an essential part of most people’s lives, and driving cessation is associated with many negative consequences including depression, loneliness and stress with loved ones. However, driving is a complex task that involves multiple thinking and motor abilities. Alzheimer’s disease and mild cognitive impairment are common among Canadians and the global population and can affect the ability to drive safely. Despite this, some patients with Alzheimer’s disease and mild cognitive impairment are able to drive safely. It is important to balance between avoiding the negative consequences that are associated with discontinued driving and the safety of patient drivers and the general public.
Unfortunately, there are no measures that doctors are able to use to accurately assess the driving fitness of patients with Alzheimer’s disease and mild cognitive impairment. As a result, many doctors do not feel confident when assessing the driving ability of their patients. In general, research suggests that some of patients with Alzheimer's disease and mild cognitive impairment are still able to drive after diagnosis, and that driving impairment is related to the severity of the disease. The purpose of this study is to determine which driving behaviours these patient groups have the most difficulty with and the brain areas that are related to these behaviours. The study will combine a driving simulator and neuroimaging technology to determine which areas of the brain are activated in these patients during a variety of driving tasks, such as right turns, left turns without traffic, and left turns with traffic. The study will also determine what types of driving errors are characteristic of patients with Alzheimer's disease and mild cognitive impairment, such as collisions, lane deviations, smaller gap distances to other vehicles, shorter time to collision, and stop signs missed.The brain activation levels and behavioural driving performance of patients with Alzheimer's disease and mild cognitive impairment will be compared to healthy older adults. Because the number of individuals with Alzheimer’s disease is going in increase greatly over the next generation, it is important to determine which driving behaviours these patients have the most difficulty with as well as their associated brain areas. This research will be an important first step to ultimately develop accurate driving assessments and. This will help maintain the independence of patients, while maintaining their safety and that of the general public.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311744
Name
Hird Megan A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Driving in Alzheimer's disease and mild cognitive impairment: An immersive fMRI study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Driving; Driving Simulator; Functional Mri (Fmri); Mild Cognitive Impairment; Neuroimaging; Virtual Reality
Abstract
Driving is an essential part of most people’s lives, and driving cessation is associated with many negative consequences including depression, loneliness and stress with loved ones. However, driving is a complex task that involves multiple thinking and motor abilities. Alzheimer’s disease and mild cognitive impairment are common among Canadians and the global population and can affect the ability to drive safely. Despite this, some patients with Alzheimer’s disease and mild cognitive impairment are able to drive safely. It is important to balance between avoiding the negative consequences that are associated with discontinued driving and the safety of patient drivers and the general public.
Unfortunately, there are no measures that doctors are able to use to accurately assess the driving fitness of patients with Alzheimer’s disease and mild cognitive impairment. As a result, many doctors do not feel confident when assessing the driving ability of their patients. In general, research suggests that some of patients with Alzheimer's disease and mild cognitive impairment are still able to drive after diagnosis, and that driving impairment is related to the severity of the disease. The purpose of this study is to determine which driving behaviours these patient groups have the most difficulty with and the brain areas that are related to these behaviours. The study will combine a driving simulator and neuroimaging technology to determine which areas of the brain are activated in these patients during a variety of driving tasks, such as right turns, left turns without traffic, and left turns with traffic. The study will also determine what types of driving errors are characteristic of patients with Alzheimer's disease and mild cognitive impairment, such as collisions, lane deviations, smaller gap distances to other vehicles, shorter time to collision, and stop signs missed.The brain activation levels and behavioural driving performance of patients with Alzheimer's disease and mild cognitive impairment will be compared to healthy older adults. Because the number of individuals with Alzheimer’s disease is going in increase greatly over the next generation, it is important to determine which driving behaviours these patients have the most difficulty with as well as their associated brain areas. This research will be an important first step to ultimately develop accurate driving assessments and. This will help maintain the independence of patients, while maintaining their safety and that of the general public.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hird, Megan A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~